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EPLY
he specific commission of our review, titled “The Year in
therothrombosis,” was to highlight clinically relevant studies in
he field published within the last year (1). The letter from Dr.
omı´nguez-Rodriguez and colleagues highlights the importance
f the circadian rhythm in the presentation of acute coronary
vents, a concept established several years ago. The last citation of
heir letter quotes a study published in 2004, evaluating the
ight/dark cycle of cytokines and melatonin plasma levels in
atients with acute myocardial infarction (AMI) (2). This single,
bservational, case-control study suggested an association between
igh levels of interleukin-6 and low levels of melatonin during the
ark cycle in patients with AMI. The investigators should be
ongratulated for their effort. However, the study is not mecha-
istic, and does not prove causality. Furthermore, the clinical
ignificance of their findings still remains to be elucidated. As a
esult, in our judgment the study may not meet the criteria to be
ncluded as a clinically relevant publication in atherothrombosis in
he year 2004.
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iruses and Other Environmental Factors as
ossible Sources of Phenotypic Heterogeneity
n Familial Dilated Cardiomyopathy
n their interesting and recent state-of-the-art study, Burkett and
ershberger (1) stated that “familial dilated cardiomyopathy
DCM) demonstrates incomplete penetrance, variable expression,
nd significant locus and allelic heterogeneity, making clinical and
enetic diagnosis complex.” The statement clearly describes a key
roblem encountered during the genetic dissection of human
CM. This problem reaches beyond the fact that multiple genes
ay cause the DCM phenotype in humans and that further loci
hall be revealed in the future. Even within a single DCM family
r within a group of unrelated DCM patients harboring defects in
he same gene, there is often very large and currently unexplained
henotypic heterogeneity. There are at least two possible sources
or this heterogeneity.
First, unless representative healthy control populations are
creened for a given mutation one cannot be sure that this
utation is capable of causing the phenotype without additional
ofactors (modifier genes or environmental agents) being present.
n other genetic disorders the screening of large control popula-
ions has been the indispensable basis for the discovery of such
ofactors. For example, smoking was identified as an essential
nvironmental factor for the development of lung disease in
enetic 1-antitrypsin deficiency, initially assumed to cause the
isease per se on a pure genetic basis. For most mutations
ssociated with DCM we do not yet have frequency data repre-
entative of the general healthy population that can be compared
ith the rather small DCM patient cohorts from which the disease
ssociation is usually derived. The relative pathogenic contribution
f the gene defect per se as compared to hitherto unknown
ofactors is therefore uncertain.
Second, data on possible environmental agents are sparse in
olecular genetic studies of familial DCM. Regarding such
ofactors, we have recently detected cardiac viral infections in 165
67.4%) of 245 cases in a molecular virological survey based on
yocardial biopsies from a series of DCM patients (2), with a
road spectrum of virus species being involved. Cardiotropic
iruses thus emerged as prevalent environmental factors that may
ossibly cause or influence the course of DCM. The high fre-
uency of cardiotropic viruses detected in that DCM series makes
t highly likely that cardiac viruses are also encountered in familial
CM. They may explain part of the large phenotypic heteroge-
eity mentioned by Burkett and Hershberger (1), but will go
nnoticed unless cardiac biopsies are specifically investigated using
olecular virological methods. A synopsis of the current data
uggests that a comprehensive picture of the pathogenesis of
amilial DCM can only be obtained if both genetic and environ-
ental factors are analyzed. Studies of this type may lead to the
